AZN icon

AstraZeneca

1,138 hedge funds and large institutions have $33.8B invested in AstraZeneca in 2024 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 485 increasing their positions, 340 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0.45% less ownership

Funds ownership: 32.57%32.12% (-0.45%)

1% less capital invested

Capital invested by funds: $34B → $33.8B (-$235M)

8% less funds holding in top 10

Funds holding in top 10: 1312 (-1)

Holders
1,138
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$480M
Puts
$470M
Net Calls
Net Calls Change

Top Sellers

1 -$903M
2 -$659M
3 -$157M
4
N
Nuveen
North Carolina
-$129M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$103M
Name Holding Trade Value Shares
Change
Change in
Stake
576
$657K
577
$652K
578
$651K
579
$643K
580
$643K
581
$640K
582
$637K
583
$634K
584
$629K
585
$627K
586
$626K
587
$624K
588
$623K
589
$612K
590
$612K
591
$606K
592
$600K
593
$600K
594
$599K
595
$598K
596
$597K
597
$593K
598
$591K
599
$588K
600
$587K